ACADIA Pharmaceuticals, Inc. (ACAD)
21.30
+0.69
(+3.35%)
USD |
NASDAQ |
Mar 16, 11:39
ACADIA Pharmaceuticals Total Liabilities (Quarterly) : 336.80M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.526B |
| Madrigal Pharmaceuticals, Inc. | 656.90M |
| Marker Therapeutics, Inc. | 3.346M |
| Agilent Technologies, Inc. | 5.905B |
| Axsome Therapeutics, Inc. | 601.51M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.564B |
| Shareholders Equity (Quarterly) | 1.227B |
| Debt to Equity Ratio | 0.0425 |
| Current Ratio | 3.833 |
| Net Debt Paydown Yield | -0.01% |